Ignite Creation Date:
2024-05-05 @ 4:49 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00321646
Status:
COMPLETED
Last Update Posted:
2016-05-16
First Post:
2006-05-02
Brief Title:
Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy
Sponsor:
Organization:
Dana-Farber Cancer Institute